News
Samsung Biologics Co., the biotech arm of South Korea's Samsung Group, announced Thursday that it plans to spin off its ...
Seoul: Samsung Biologics, a biotech arm of South Korea's Samsung Group, said on Thursday it plans to spin off its biosimilar ...
The Manila Times on MSN17h
Samsung BioLogics spin-off to separate contract drug making, new growth driversSEOUL ― South Korean drugmaker Samsung BioLogics said on Thursday it plans to separate the company into contract manufacturing and development companies to help allay customer concerns about conflicts ...
In a bid to allay conflict-of-interest concerns, Korean manufacturing giant Samsung Biologics is decoupling from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback